Region:Middle East
Author(s):Dev
Product Code:KRAD7835
Pages:96
Published On:December 2025

By Care Setting:The market is segmented into various care settings, including Assisted Living Facilities with On-site Neurorehabilitation, Standalone Inpatient Neurorehabilitation Centers, Outpatient / Day-Care Neurorehabilitation Clinics, Home- and Community-Based Neurorehabilitation Programs, and Tele-Neurorehabilitation Services. Each of these settings caters to different patient needs and preferences, with a growing trend towards outpatient, day-care, and home-based models that align with Saudi Arabia’s focus on shifting care from hospital-centric to community-based services, improving patient convenience and cost-effectiveness while maintaining continuity of multidisciplinary rehabilitation.

By Clinical Indication:The market is also segmented by clinical indications, including Stroke and Cerebrovascular Disease, Traumatic Brain Injury (TBI), Spinal Cord Injury, Parkinson’s Disease and Movement Disorders, Multiple Sclerosis and Demyelinating Disorders, Cognitive Impairment and Dementia, and Others. Stroke and cerebrovascular diseases represent the largest segment due to their high and growing burden in Saudi Arabia and the region, where stroke prevalence and neurological disease–related DALYs are substantial, driving sustained demand for early and intensive neurorehabilitation to reduce long-term disability.

The KSA Assisted Living Facility Neurorehabilitation Market is characterized by a dynamic mix of regional and international players. Leading participants such as King Fahad Medical City – Rehabilitation Hospital (Riyadh), King Khalid University Hospital – Neurorehabilitation Services (Riyadh), King Faisal Specialist Hospital & Research Centre – Neurosciences and Rehabilitation (Riyadh/Jeddah), Dr. Sulaiman Al Habib Medical Group – Rehabilitation & Long-Term Care Hospitals, Saudi German Hospital Group – Neuroscience and Rehabilitation Centers (Jeddah/Riyadh/Dammam), Almana Group of Hospitals – Physical Medicine & Neurorehabilitation (Eastern Province), Almoosa Health Group – Rehabilitation and Neurorehabilitation Center (Al Ahsa), Sultan Bin Abdulaziz Humanitarian City – Rehabilitation Medical City (Riyadh), Prince Sultan Military Medical City – Rehabilitation Medicine Department (Riyadh), King Fahd University Hospital – Rehabilitation & Neurorehabilitation Unit (Al Khobar), National Guard Health Affairs – Rehabilitation Services (Riyadh/Jeddah/Dammam), King Abdulaziz Medical City – Neurosciences and Rehabilitation (Riyadh), Dr. Erfan & Bagedo General Hospital – Neurorehabilitation and Physiotherapy (Jeddah), International Extended Care Center (IECC) – Long-Term Care & Rehabilitation (Riyadh), Saudi German Rehabilitation Hospital (Riyadh) contribute to innovation, geographic expansion, and service delivery in this space.
The future of the KSA assisted living facility neurorehabilitation market appears promising, driven by demographic changes and increasing healthcare investments. As the aging population grows and neurological disorders become more prevalent, the demand for specialized rehabilitation services will likely rise. Innovations in telehealth and personalized care models are expected to enhance service delivery, making neurorehabilitation more accessible. Additionally, partnerships with healthcare providers will facilitate integrated care solutions, further supporting market growth and improving patient outcomes.
| Segment | Sub-Segments |
|---|---|
| By Care Setting | Assisted Living Facilities with On-site Neurorehabilitation Standalone Inpatient Neurorehabilitation Centers Outpatient / Day-Care Neurorehabilitation Clinics Home- and Community-Based Neurorehabilitation Programs Tele?Neurorehabilitation Services |
| By Clinical Indication | Stroke and Cerebrovascular Disease Traumatic Brain Injury (TBI) Spinal Cord Injury Parkinson’s Disease and Movement Disorders Multiple Sclerosis and Demyelinating Disorders Cognitive Impairment and Dementia Others |
| By Facility Ownership | Government / Public Hospitals and Rehabilitation Centers Private Hospitals and Specialist Rehabilitation Centers Non?Profit and Charity-Run Facilities Others |
| By Therapy Modality | Physical and Gait Therapy Occupational Therapy and ADL Training Speech and Swallowing Therapy Neuropsychology and Cognitive Rehabilitation Technology-Assisted Therapy (Robotics, VR, Gaming Systems, BCIs) Others |
| By Payment & Reimbursement Model | Self?Pay / Out?of?Pocket Cooperative / Private Health Insurance Government-Funded and Public Insurance Schemes Corporate and Occupational Health Contracts Others |
| By Duration of Care | Short-Term Post?Acute Rehabilitation (< 3 Months) Medium-Term Rehabilitation (3–12 Months) Long-Term and Continuing Care (> 12 Months) Others |
| By Region in KSA | Riyadh Region Makkah Region (including Jeddah) Eastern Province (including Dammam, Al Khobar, Dhahran) Madinah and Western Region Other Regions |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Assisted Living Facilities | 100 | Facility Managers, Healthcare Administrators |
| Neurorehabilitation Service Providers | 80 | Rehabilitation Therapists, Clinical Directors |
| Patient Family Perspectives | 60 | Family Members of Patients, Caregivers |
| Healthcare Policy Makers | 50 | Government Officials, Health Policy Analysts |
| Insurance Providers | 40 | Insurance Underwriters, Claims Adjusters |
The KSA Assisted Living Facility Neurorehabilitation Market is valued at approximately USD 1.1 billion, reflecting a significant growth driven by the increasing prevalence of neurological disorders and advancements in rehabilitation technologies.